-Secretase Modulators: Can We Combine Potency with Safety?
-Secretase modulation has been proposed as a potential disease modifying anti-Alzheimer’s approach. -Secretase modulators (GSMs) cause a product shift from the longer amyloid-beta (Aβ) peptide isoforms to shorter, more soluble, and less amyloidogenic isoforms, without inhibiting APP or Notch proteol...
Main Authors: | Harrie J. M. Gijsen, Marc Mercken |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | International Journal of Alzheimer's Disease |
Online Access: | http://dx.doi.org/10.1155/2012/295207 |
Similar Items
-
γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not
by: Christian B. Lessard, et al.
Published: (2020-05-01) -
Modulators of γ-secretase activity can facilitate the toxic side-effects and pathogenesis of Alzheimer's disease.
by: Željko M Svedružić, et al.
Published: (2013-01-01) -
Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease
by: Barbara Tate, et al.
Published: (2012-01-01) -
Correction: Modulators of γ-Secretase Activity Can Facilitate the Toxic Side-Effects and Pathogenesis of Alzheimer's Disease
by: Željko M. Svedružić, et al.
Published: (2013-01-01) -
Correction: Modulators of γ-Secretase Activity Can Facilitate the Toxic Side-Effects and Pathogenesis of Alzheimer's Disease.
by: Željko M. Svedružić, et al.
Published: (2013-01-01)